453 related articles for article (PubMed ID: 29564664)
1. Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation.
Regueiro A; Cruz-Gonzalez I; Bethencourt A; Nombela-Franco L; Champagne J; Asmarats L; Jiménez-Quevedo P; Rodriguez-Gabella T; Rama-Merchan JC; Puri R; O'Hara G; Rodés-Cabau J
J Interv Card Electrophysiol; 2018 Jun; 52(1):53-59. PubMed ID: 29564664
[TBL] [Abstract][Full Text] [Related]
2. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
5. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
[TBL] [Abstract][Full Text] [Related]
7. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
Berti S; Pastormerlo LE; Rezzaghi M; Trianni G; Paradossi U; Cerone E; Ravani M; De Caterina AR; Rizza A; Palmieri C
Heart; 2016 Dec; 102(24):1969-1973. PubMed ID: 27492943
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
[TBL] [Abstract][Full Text] [Related]
11. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years.
Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H
JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events.
Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Pasquie JL; Rioufol G; Lepillier A; Elbaz M; Horvilleur J; Brenot P; Pierre B; Le Corvoisier P;
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005841. PubMed ID: 29540492
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
[TBL] [Abstract][Full Text] [Related]
16. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
17. Left Atrial Appendage Closure for Atrial Fibrillation Is Safe and Effective After Intracranial or Intraocular Hemorrhage.
Fahmy P; Spencer R; Tsang M; Gooderham P; Saw J
Can J Cardiol; 2016 Mar; 32(3):349-54. PubMed ID: 26831513
[TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage closure - new choice for no-option patients with atrial fibrillation.
Grygier M; Olasinska-Wisniewska A; Trojnarska O; Lesiak M; Araszkiewicz A; Mularek-Kubzdela T; Grajek S
Minerva Cardioangiol; 2015 Dec; 63(6):577-86. PubMed ID: 24743471
[TBL] [Abstract][Full Text] [Related]
19. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
[TBL] [Abstract][Full Text] [Related]
20. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
